Question 1

What specific benefits do you think I might gain from participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study to Assess the Pharmacokinetics of Ramucirumab (IMC-1121B) in Combination With FOLFIRI clinical trial (NCT01634555). Contact the study team or your healthcare provider for specific answers.

Question 2

How does ramucirumab work in combination with FOLFIRI?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study to Assess the Pharmacokinetics of Ramucirumab (IMC-1121B) in Combination With FOLFIRI clinical trial (NCT01634555). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the potential side effects I should be aware of?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study to Assess the Pharmacokinetics of Ramucirumab (IMC-1121B) in Combination With FOLFIRI clinical trial (NCT01634555). Contact the study team or your healthcare provider for specific answers.

Question 4

How often would I need to come in for treatments and check-ups?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study to Assess the Pharmacokinetics of Ramucirumab (IMC-1121B) in Combination With FOLFIRI clinical trial (NCT01634555). Contact the study team or your healthcare provider for specific answers.

Question 5

Are there any other treatment options I should consider instead of this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study to Assess the Pharmacokinetics of Ramucirumab (IMC-1121B) in Combination With FOLFIRI clinical trial (NCT01634555). Contact the study team or your healthcare provider for specific answers.

Question 6

What happens if I experience side effects or complications during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study to Assess the Pharmacokinetics of Ramucirumab (IMC-1121B) in Combination With FOLFIRI clinical trial (NCT01634555). Contact the study team or your healthcare provider for specific answers.

What this study is about